Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces CSPA Group Inc. and LDS Scientific’s debut of CannaStripsTM and the Rêveur luxury brand of cannabis products for the California market during the Indio, CA desert festival weekends, which will take place on April 13-15, April 20-22 and April 27-29, 2018.
The products will be available from local delivery services and information on the products will be available at the CannaStripsTM/Rêveur promotion suite during all of the April 2018 Indio, CA desert festivals at the Base Camp enclave poolside, where exclusive special promotional coupons will be available.
CSPA Group Inc. has been test marketing five new 10-mg formula versions of CannaStripsTM. The following versions were used in the test marketing:
- 10 mg THC full spectrum strip with trace amounts of CBD and CBN;
- 5 mg THC and 5 mg CBD 50/50 blend;
- 8 mg CBD and 2 mg THC;
- the sleep version with 8 mg CBD, 2 mg THC, melatonin and serotonin; and
- 8 mg CBD 2 mg THCa, 10 mg curcumin with trace amounts of CBN and CBG.
The CEO of LDS, Brad Eckenweiler, commented, “These five versions represent the results of our market research combined with customer comments, requests and suggestions received over the past three months. The resulting products, we believe, represent the best combinations of ingredients to meet the demands of the current market given the regulatory guidelines.” The Company’s latest packaging and logo designs for CannaStripsTM and Rêveur will be posted on Reveurbrands.com, Cannastrips.com and LifestyleDeliverySystems.com, as early as on Tuesday, April 10, 2018.
You may be interested
Aurora Cannabis Provides Investors Updates on their International OperationsEditor - August 13, 2018
Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) announced this morning a company update on their multiple cannabis related operations around the world. The company has undertaken projects in numerous…
Australians Overwhelmingly Support Medical CannabisEditor - August 13, 2018
Ninety one percent of Australians support medicinal cannabis use. Chronic diseases like epilepsy, chronic pain, nausea in cancer related chemotherapy, multiple sclerosis, PTSD, and palliative care are…
Health Canada Issues Significant Changes to Industrial Hemp RegulationsEditor - August 11, 2018
Health Canada, the overseeing body in charge of industrial hemp licensing and its regulations has just issued a new class exemption for cultivators of the plant within…